New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 8, 2014
09:14 EDTPATH, FRX, TWTR, STZ, MCD, JCP, MSFT, TCS, TEVA, RAD, F, ENDP, MUOn The Fly: Pre-market Movers
UP AFTER EARNINGS: Micron (MU), up 10%... Constellation Brands (STZ), up 7%... Apollo Education (APOL), up 8%. ALSO HIGHER: Forest Laboratories (FRX), up 14% after acquiring Aptalis for $2.9B in cash... Rite Aid (RAD), up 2.6% following upgrade at JPMorgan... NuPathe (PATH), up 36% after receiving takeover bid from Teva (TEVA) to rival formerly agreed to deal with Endo Health (ENDP)... Ford (F), up 1.6% after AP says CEO Mulally staying at Ford. Microsoft (MSFT), down 0.6% after the news, as Mulally was viewed as a candidate for its CEO opening... ALSO LOWER: The Container Store (TCS), down 10.4% after earnings, downgrade at BofA Merrill Lynch... J.C. Penney (JCP), down 6.3% after backing Q4 outlook but not providing December same-store sales figure... Twitter (TWTR), down 4% following downgrade at Cantor... McDonald's (MCD), down 1% following downgrade at Wells Fargo.
News For TWTR;F;MSFT;FRX;RAD;JCP;PATH;TEVA;MCD;MU;TCS;STZ;ENDP From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | all recent news | >>
February 24, 2015
07:30 EDTSTZJPMorgan to hold a conference
Global High Yield & Leveraged Finance Conference is being held in Miami Beach, FL on February 23-25 with webcasted company presentations to begin on February 24 at 7:40 am; not all company presentations may be webcasted. Webcast Link
06:48 EDTJCPPiper reiterates J.C. Penney as top pick for 2015
Piper Jaffray analyst Neely Tamminga reiterates J.C. Penney as a top pick for 2015 ahead of the retailer's year-end 2014 earnings report. Tamminga believes Penny's comp for February, the first month of its fiscal year, could be tracking up 4%. The analyst also thinks Penny management could express conviction in the retailer's plan to recapture share among moderate consumers on Thursday's earnings call. Tamminga has an Overweight rating on Penny with a $12 price target.
05:09 EDTFFord launches training program at Kansas City plant to support F-150 production
Subscribe for More Information
February 23, 2015
16:00 EDTTWTROptions Update; February 23, 2015
Subscribe for More Information
15:04 EDTTEVATeva announces publication of data on Phase III trials of reslizumab
Subscribe for More Information
12:53 EDTENDPAnalysts debate potential for competing Salix takeover bid
Subscribe for More Information
10:46 EDTTWTRTwitter urges FCC to adopt 'common sense' net neutrality rules
Subscribe for More Information
10:38 EDTMUMicron management to meet with Pacific Crest
Subscribe for More Information
09:39 EDTTWTRActive equity options trading on open
Subscribe for More Information
09:02 EDTENDPAcceptance of NDA for Belbuca triggers $10M milestone payment to BDSI
Subscribe for More Information
07:31 EDTENDPEndo, BioDelivery Sciences announce acceptance of NDA for Belbuca
Subscribe for More Information
06:06 EDTRADStocks with implied volatility movement; JNJ NUGT
Stocks with implied volatility movement; Halliburton (HAL) 32, Rite Aid (RAD) 34 according to iVolatility.
February 22, 2015
15:59 EDTENDPValeant to buy Salix for $10.1B, FT says
Subscribe for More Information
15:31 EDTMCDMcDonald's under pressure to raise hourly pay as Wal-Mart sets bar, Reuters says
According to labor experts McDonald's (MCD) and its franchisees may be under pressure to raise hourly wages as the improved economic landscape increases competition for good workers and as retailer Wal-Mart (WMT) raises its hourly pay, says Reuters. Reference Link
February 20, 2015
16:03 EDTMCDOptions Update; February 20, 2015
Subscribe for More Information
09:38 EDTTWTR, MCDActive equity options trading on open
Subscribe for More Information
09:17 EDTENDPEndo price target raised to $101 from $86 at Goldman
Subscribe for More Information
08:21 EDTENDPSummer Street still feels Endo could acquire BioDelivery Sciences
Summer Street reiterated its belief that Endo (ENDP) could acquire BioDelivery Sciences (BDSI), its partner on multiple products. The firm says scripts for BioDelivery's Bunavail continue to trend in the right direction. It reiterates a Buy rating on the stock with a $25 price target.
08:04 EDTTEVATeva to present new respiratory data at AAAAI
Teva Pharmaceutical Industries announced that four company-sponsored abstracts will be presented at the 2015 Annual Meeting of the American Academy of Allergy, Asthma and Immunology, or AAAAI, in Houston, Texas. Data to be presented include two replicate 52-week Phase III global studies of the company’s anti-IL5 monoclonal antibody, reslizumab, in patients with asthma and elevated blood eosinophils who were inadequately controlled on medium-to-high doses of inhaled corticosteroids with or without an additional controller. The data are scheduled for presentation on Monday, February 23 during an oral session titled “Asthma Therapy and Mechanisms.” Also to be presented are two Phase III studies of beclomethasone dipropionate 40mcg, which gained FDA approval in December 2014, and is now available for the treatment of nasal symptoms associated with allergic rhinitis in children 4-11 years of age. In addition, a dose-response study evaluating the safety and efficacy of fluticasone/salmeterol multidose dry-powder inhaler in patients 12 years of age and older with persistent asthma will be presented.
07:08 EDTTEVAAmerican Academy of Allergy, Asthma and Immunology to hold annual meeting
2015 Annual Meeting of AAAAI is being held in Houston, Texas on February 20-24.
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use